Targeting cannabinoid receptor signaling for drug discovery and characterization: A focus on CB1 and CB2 cannabinoid receptors and GIRK1/GIRK2 potassium channels KU Leuven
In cannabinoid (CB) receptor signaling, CB1 and CB2 receptors and G protein-coupled inwardly rectifying potassium (GIRK1/GIRK2) channels have attracted considerable attention from scientists in investigating their therapeutic potential for diverse diseases, especially in neurological diseases.
CB1 and CB2 receptors, the G protein-coupled receptors (GPCRs) and members of the endocannabinoid system, are pleiotropic signaling molecules and ...